Literature DB >> 21594291

Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells.

Lei Wang1, Andre Alcon, Hongwei Yuan, Jeffrey Ho, Qi-Jing Li, M Martins-Green.   

Abstract

Prostate cancer is the second leading cause of cancer-related deaths among US males. Pomegranate juice (PJ), a natural product, was shown in a clinical trial to inhibit progression of this disease. However, the underlying mechanisms involved in the anti-progression effects of PJ on prostate cancer remain unclear. Here we show that, in addition to causing cell death of hormone-refractory prostate cancer cells, PJ also increases cell adhesion and decreases cell migration of the cells that do not die. We hypothesized that PJ does so by stimulating the expression and/or activation of molecules that alter the cytoskeleton and the adhesion machinery of prostate cancer cells, resulting in enhanced cell adhesion and reduced cell migration. We took an integrative approach to these studies by using Affimetrix gene arrays to study gene expression, microRNA arrays to study the non-coding RNAs, molecules known to be disregulated in cancer cells, and Luminex Multiplex array assays to study the level of secreted pro-inflammatory cytokines/chemokines. PJ up-regulates genes involved in cell adhesion such as E-cadherin, intercellular adhesion molecule 1 (ICAM-1) and down-regulates genes involved in cell migration such as hyaluranan-mediated motility receptor (HMMR) and type I collagen. In addition, anti-invasive microRNAs such as miR-335, miR-205, miR-200, and miR-126, were up-regulated, whereas pro-invasive microRNA such as miR-21 and miR-373, were down-regulated. Moreover, PJ significantly reduced the level of secreted pro-inflammatory cytokines/chemokines such as IL-6, IL-12p40, IL-1β and RANTES, thereby having the potential to decrease inflammation and its impact on cancer progression. PJ also inhibits the ability of the chemokine SDF1α to chemoattract these cancer cells. SDF1α and its receptor CXCR4 are important in metastasis of cancer cells to the bone. Discovery of the mechanisms by which this enhanced adhesion and reduced migration are accomplished can lead to sophisticated and effective prevention of metastasis in prostate and potentially other cancers. This journal is © The Royal Society of Chemistry 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21594291     DOI: 10.1039/c0ib00122h

Source DB:  PubMed          Journal:  Integr Biol (Camb)        ISSN: 1757-9694            Impact factor:   2.192


  22 in total

Review 1.  MicroRNA, nutrition, and cancer prevention.

Authors:  Sharon A Ross; Cindy D Davis
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

2.  Tumor microRNA-335 expression is associated with poor prognosis in human glioma.

Authors:  Jian Jiang; Xiaoyang Sun; Weijie Wang; Xiaodong Jin; Xiangfei Bo; Zhengming Li; Aimiao Bian; Ji Jiu; Xiaodong Wang; Dai Liu; Xiaobo Hui; Yanping Wang; Aifeng Wang; Lianshu Ding
Journal:  Med Oncol       Date:  2012-05-27       Impact factor: 3.064

3.  Luteolin, ellagic acid and punicic acid are natural products that inhibit prostate cancer metastasis.

Authors:  Lei Wang; Wenfang Li; Muqing Lin; Monika Garcia; David Mulholland; Michael Lilly; Manuela Martins-Green
Journal:  Carcinogenesis       Date:  2014-07-14       Impact factor: 4.944

4.  A Huaier polysaccharide reduced metastasis of human hepatocellular carcinoma SMMC-7721 cells via modulating AUF-1 signaling pathway.

Authors:  Cong Li; Xia Wu; Honghai Zhang; Gengxia Yang; Meijun Hao; Shoupeng Sheng; Yu Sun; Jiang Long; Caixia Hu; Xicai Sun; Li Li; Jiasheng Zheng
Journal:  Tumour Biol       Date:  2015-03-19

5.  The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers.

Authors:  Weijie Chen; Fengfeng Cai; Bei Zhang; Zeinab Barekati; Xiao Yan Zhong
Journal:  Tumour Biol       Date:  2012-12-14

6.  Analysis of pomegranate juice components in rat corpora cavernosal relaxation.

Authors:  C V Oztekin; S Gur; N A Abdulkadir; M Kartal; M Karabakan; A O Akdemir; C S Gökkaya; M Cetinkaya
Journal:  Int J Impot Res       Date:  2013-08-01       Impact factor: 2.896

Review 7.  Pomegranate extracts and cancer prevention: molecular and cellular activities.

Authors:  Deeba N Syed; Jean-Christopher Chamcheu; Vaqar M Adhami; Hasan Mukhtar
Journal:  Anticancer Agents Med Chem       Date:  2013-10       Impact factor: 2.505

8.  MicroRNA-335 acts as a candidate tumor suppressor in prostate cancer.

Authors:  Si-wei Xiong; Tian-xin Lin; Ke-wei Xu; Wen Dong; Xiao-hui Ling; Fu-neng Jiang; Guo Chen; Wei-de Zhong; Jian Huang
Journal:  Pathol Oncol Res       Date:  2013-03-03       Impact factor: 3.201

9.  Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis.

Authors:  Lei Wang; Jeffrey Ho; Carlotta Glackin; Manuela Martins-Green
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

10.  A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy.

Authors:  Stephen J Freedland; Michael Carducci; Nils Kroeger; Alan Partin; Jian-Yu Rao; Yusheng Jin; Susan Kerkoutian; Hong Wu; Yunfeng Li; Patricia Creel; Kelly Mundy; Robin Gurganus; Helen Fedor; Serina A King; Yanjun Zhang; David Heber; Allan J Pantuck
Journal:  Cancer Prev Res (Phila)       Date:  2013-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.